Atlas Trials

Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes

Clinical trial NCT04127084 · UNKNOWN

Trial details

NCT number
NCT04127084
Sponsor
Zhongshan Hospital Xiamen University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DiabetesDiabetic Nephropathy
Start date
2019-10-15
Primary completion
2020-10-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.